90 related articles for article (PubMed ID: 22669677)
1. Epigenetic approaches and methods in developmental toxicology: role of HDAC inhibition in teratogenic events.
Menegola E; Cappelletti G; Di Renzo F
Methods Mol Biol; 2012; 889():373-83. PubMed ID: 22669677
[TBL] [Abstract][Full Text] [Related]
2. Boric acid inhibits embryonic histone deacetylases: a suggested mechanism to explain boric acid-related teratogenicity.
Di Renzo F; Cappelletti G; Broccia ML; Giavini E; Menegola E
Toxicol Appl Pharmacol; 2007 Apr; 220(2):178-85. PubMed ID: 17320131
[TBL] [Abstract][Full Text] [Related]
3. Teratogenic effects mediated by inhibition of histone deacetylases: evidence from quantitative structure activity relationships of 20 valproic acid derivatives.
Eikel D; Lampen A; Nau H
Chem Res Toxicol; 2006 Feb; 19(2):272-8. PubMed ID: 16485903
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of histone deacetylase activity on specific embryonic tissues as a new mechanism for teratogenicity.
Menegola E; Di Renzo F; Broccia ML; Prudenziati M; Minucci S; Massa V; Giavini E
Birth Defects Res B Dev Reprod Toxicol; 2005 Oct; 74(5):392-8. PubMed ID: 16193500
[TBL] [Abstract][Full Text] [Related]
5. The inhibition of embryonic histone deacetylases as the possible mechanism accounting for axial skeletal malformations induced by sodium salicylate.
Di Renzo F; Cappelletti G; Broccia ML; Giavini E; Menegola E
Toxicol Sci; 2008 Aug; 104(2):397-404. PubMed ID: 18483001
[TBL] [Abstract][Full Text] [Related]
6. Relationship between embryonic histonic hyperacetylation and axial skeletal defects in mouse exposed to the three HDAC inhibitors apicidin, MS-275, and sodium butyrate.
Di Renzo F; Broccia ML; Giavini E; Menegola E
Toxicol Sci; 2007 Aug; 98(2):582-8. PubMed ID: 17517827
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of histone deacetylases.
Huang Y; Shaw PG; Davidson NE
Methods Mol Biol; 2011; 791():297-311. PubMed ID: 21913088
[TBL] [Abstract][Full Text] [Related]
8. Cardiac histones are substrates of histone deacetylase activity in hemorrhagic shock and resuscitation.
Lin T; Alam HB; Chen H; Britten-Webb J; Rhee P; Kirkpatrick J; Koustova E
Surgery; 2006 Mar; 139(3):365-76. PubMed ID: 16546502
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic modifications in valproic acid-induced teratogenesis.
Tung EW; Winn LM
Toxicol Appl Pharmacol; 2010 Nov; 248(3):201-9. PubMed ID: 20705080
[TBL] [Abstract][Full Text] [Related]
10. The Effects of Class-Specific Histone Deacetylase Inhibitors on the Development of Limbs During Organogenesis.
Paradis FH; Hales BF
Toxicol Sci; 2015 Nov; 148(1):220-8. PubMed ID: 26251326
[TBL] [Abstract][Full Text] [Related]
11. Short-time gene expression response to valproic acid and valproic acid analogs in mouse embryonic stem cells.
Jergil M; Forsberg M; Salter H; Stockling K; Gustafson AL; Dencker L; Stigson M
Toxicol Sci; 2011 Jun; 121(2):328-42. PubMed ID: 21427059
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of histone deacetylase as a new mechanism of teratogenesis.
Menegola E; Di Renzo F; Broccia ML; Giavini E
Birth Defects Res C Embryo Today; 2006 Dec; 78(4):345-53. PubMed ID: 17315247
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylation as a target for radiosensitization.
Cerna D; Camphausen K; Tofilon PJ
Curr Top Dev Biol; 2006; 73():173-204. PubMed ID: 16782459
[TBL] [Abstract][Full Text] [Related]
14. Valproic acid: an old drug newly discovered as inhibitor of histone deacetylases.
Göttlicher M
Ann Hematol; 2004; 83 Suppl 1():S91-2. PubMed ID: 15124690
[TBL] [Abstract][Full Text] [Related]
15. VPA-related axial skeletal defects and apoptosis: a proposed event cascade.
Di Renzo F; Broccia ML; Giavini E; Menegola E
Reprod Toxicol; 2010 Jan; 29(1):106-12. PubMed ID: 19850124
[TBL] [Abstract][Full Text] [Related]
16. Effect of the enucleation procedure on the reprogramming potential and developmental capacity of mouse cloned embryos treated with valproic acid.
Costa-Borges N; Gonzalez S; Santaló J; Ibáñez E
Reproduction; 2011 Jun; 141(6):789-800. PubMed ID: 21444624
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitors in cancer therapy.
Lane AA; Chabner BA
J Clin Oncol; 2009 Nov; 27(32):5459-68. PubMed ID: 19826124
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase as therapeutic target in a rodent model of hemorrhagic shock: effect of different resuscitation strategies on lung and liver.
Lin T; Chen H; Koustova E; Sailhamer EA; Li Y; Shults C; Liu B; Rhee P; Kirkpatrick J; Alam HB
Surgery; 2007 Jun; 141(6):784-94. PubMed ID: 17560255
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibitors induce apoptosis, histone hyperacetylation and up-regulation of gene transcription in Schistosoma mansoni.
Dubois F; Caby S; Oger F; Cosseau C; Capron M; Grunau C; Dissous C; Pierce RJ
Mol Biochem Parasitol; 2009 Nov; 168(1):7-15. PubMed ID: 19538992
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide screening for target regions of histone deacetylases in cardiomyocytes.
Kaneda R; Ueno S; Yamashita Y; Choi YL; Koinuma K; Takada S; Wada T; Shimada K; Mano H
Circ Res; 2005 Aug; 97(3):210-8. PubMed ID: 16002748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
